The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A

BACKGROUND: Risk factors for the development of inhibitors in previously untreated patients (PUPs) have been reported; this is not the case in previously treated patients (PTPs) owing to fewer studies. Risk factors may differ for the development of PTP versus PUP inhibitors. We aimed to identify ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ju Young, You, Chur Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779946/
https://www.ncbi.nlm.nih.gov/pubmed/31730688
http://dx.doi.org/10.5045/br.2019.54.3.204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779946/
https://www.ncbi.nlm.nih.gov/pubmed/31730688
http://dx.doi.org/10.5045/br.2019.54.3.204

Ejemplares similares